XBiotech Inc. (NASDAQ: XBIT)
$7.1300
+0.3000 ( +2.00% ) 11.2K
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Market Data
Open
$7.1300
Previous close
$6.8300
Volume
11.2K
Market cap
$217.50M
Day range
$6.6850 - $7.1700
52 week range
$3.6000 - $9.9600
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 44 | Nov 13, 2024 |
| 10-q | Quarterly Reports | 44 | Aug 12, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 21, 2024 |
| 8-k | 8K-related | 13 | Jun 20, 2024 |
| 10-q | Quarterly Reports | 44 | May 10, 2024 |
| ars | Annual reports | 1 | May 01, 2024 |
| def | Proxies and info statements | 5 | May 01, 2024 |